Alzheimer’s disease

As in the previous year, Neuropenews asked EAN committee members, panel chairs, speakers etc. which session one should not miss at the upcoming congress in Berlin, June 2015. Please find their answers below! Benedikt Schoser, speaker at Symposium 3 “Modern… Continue Reading

In the June issue of the European Journal of Neurology, members of the Subspecialty Scientific Panel Dementia and Cognitive Disorders panel of the European Academy of Neurology publish a Guideline on concomitant use of cholinesterase inhibitors (ChEI) and memantine in moderate to severe Alzheimer’s disease (AD).

by Martin Rakusa Over 3000 neurologists, psychiatrists and neuroscientists have recently gathered together at the French Mediterranean coast. From 18th to 22nd of March, Nice hosted the 12th International Conference on Alzheimer’s and Parkinson’s Diseases and related Neurological Disorders (AD/PD… Continue Reading

As in the previous year, Neuropenews asked EAN committee members, panel chairs, speakers, … which session one should not miss at the upcoming congress in Berlin, June 2015. Please find their answers below …

The European Brain Council sends out a newsletter as well as an External Environmental Report that brings articles and projects of interest to the attention of its members. From these, the Neuropenews Editors identify those that are of interest for… Continue Reading

As in the previous year, Neuropenews asked EAN committee members, panel chairs, speakers, … which session one should not miss at the upcoming congress in Berlin, June 2015. Please find their answers below …

Dear colleagues, On behalf of the European Academy of Neurology and the European Alzheimer’s disease consortium (EADC), we would like to invite all members to express their opinion regarding the use of Mild Cognitive Impairment (MCI) in current European practice… Continue Reading

Below are articles of special interest recommended in the last issue of the
EBC – external environment report:
2nd HBP Education Workshop: “Future Medicine” (Horizon 2020) The aim of the second Human Brain Project Education Workshop is to introduce the… Continue Reading

The couple of papers that I would like to point out to our readers are strictly related, and their relevance stream out of the fact that at least 1 person is diagnosed every minute with neurodegenerative dementia ( mainly Alzheimer’s disease, but FTD and Lewy Body Disease as well), but scientists have not yet found a cure for both the disease itself and/or its symptoms progression.

No doubt, the evidence is piling up: misfolded protein pathologies can spread throughout the nervous system in a prion-like fashion. Diseases and proteins concerned include Alzheimer’s disease and frontotemporal lobe dementia (Tau), amyotrophic lateral sclerosis (SOD1) and Parkinson’s disease (α-synuclein).… Continue Reading

Dear readers, here are a couple of papers published in the previous months, with a few lines explaining why these papers appear worth signalling over the many others that had not aroused a particular attention.

With Alzheimer’s disease and other forms of dementia on the rise worldwide, this subject has high priority in medical research. Groups of European researchers gave more than 50 presentations on dementia alone at the Congress of the European Neurological Society… Continue Reading

by Reinhold Schmidt Longitudinal population-based studies have provided important information on the prevalence and incidence of dementia and it´s subtypes in the general population However, such studies consider incident dementia as an endpoint because their design is not suited to… Continue Reading

The Editors have – together with the Scientific Committee – decided that new guideline papers will be presented in the Forum of NEUROPENEWS. In the September 2012 issue of the European Journal of Neurology the new EFNS guideline paper on… Continue Reading

Philip Scheltens, Chair of the EFNS Scientist Panel Cognitive Neurology and Dementia